Hydroxyethyl Starch 40 or 130 API Raw Material

Product Details
Customization: Available
Function: Blood System Agents
Certification: GMP
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP
  • Hydroxyethyl Starch 40 or 130 API Raw Material
  • Hydroxyethyl Starch 40 or 130 API Raw Material
  • Hydroxyethyl Starch 40 or 130 API Raw Material
  • Hydroxyethyl Starch 40 or 130 API Raw Material
  • Hydroxyethyl Starch 40 or 130 API Raw Material
  • Hydroxyethyl Starch 40 or 130 API Raw Material
Find Similar Products

Basic Info.

Model NO.
CAS: 9005-27-0
Grade Standard
Medicine Grade
Type
Chemical Reagent
State
Solid
Volatile
Not Volatile
Manufacturer
Yes
Transport Package
Carton or Drum
Trademark
SHIMEN
Origin
Hebei China
Production Capacity
500000

Product Description

Hydroxyethyl Starch

Generic Name: Hydroxyethyl Starch

CAS: 9005-27-0

Indication: This product is a plasma volume expansion agent.  For the treatment and prevention of hypovolemia or shock associated with surgery, hemorrhagic shock, trauma, traumatic shock, infection, septic shock, burn, burn shock;  Reduce the need for blood supply during surgery and economize on blood use: for example, acute isovolemic hemodilution (ANH);  Therapeutic hemodilution.  

Hydroxyethyl Starch 40 or 130 API Raw Material
SSY Group Limited, established in 1948, principally specializes in R&D, manufacture, and sale of a widerange of pharmaceutical products, including various dosage forms such as intravenous injections, tablets, capsule, ampoules, APIs and medical packaging materials.The main subsidiaries of SSY are as follows
Shijiazhuang No 4 Pharmaceutical Co, Ltd
Hebei Guangxiang Pharmaceutical Co, Ltd.
Hebei Guolong Pharmaceutical Co, Ltd
Jiangsu Best New Medical Material Co, Ltd.

Hebei Hanlin Bio-tech Co., Ltd.
With more than 70-year development, our products
have been sold to both domestic and overseas markets up to more than 80 countries and regions. 


Hebei Guangxiang Pharmaceutical Co., Ltd. is a super-large pharmaceutical enterprise, with 3 billion RMB investment and an area of 1000mu(equals to about 667,000m2) in the Biomedical Industrial Park of Cangzhou Bohai New Area. It seizes the timely opportunity of Beijing-Tianjin-Hebei integrated development and firmly relies on the abundant capital, R&D strength and brand influence of SSY Group. Concentrating on API, intermediate compounds and bio-pharmaceutical preparations, its main products are API series products, metronidazole, nifedipine, theophylline, aminophylline, azithromycin, abidol and other series of products and biomedical preparations.

The manufacturing of main products among them- API series products replaces traditional intermittent production into intelligent continuous production with advanced process equipment, automation and information technology, greatly improving production efficiency.

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier